Clinical Trials List
Protocol NumberT3214
Not yet recruiting
2015-01-31 - 2018-01-31
Phase II
Terminated3
-
Trial Applicant
National Health Research Institutes
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Principal Investigator
Co-Principal Investigator
- Chiun Hsu Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- 王秀伯 Division of General Internal Medicine
- 林宗哲 Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Co-Principal Investigator
- Yu-Min Yeh Division of Hematology & Oncology
- Yan-Shen Shan Division of General Surgery
- Wei-Pang Chung Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
- Hui-Jen Tsai Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Co-Principal Investigator
- 呂理駿 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
34-35 participants
-
Global
0 participants
